Irsogladine
Irsogladine is a phosphodiesterase inhibitor.[1]
 | |
| Names | |
|---|---|
| Preferred IUPAC name
6-(2,5-Dichlorophenyl)1,3,5-triazine-2,4-diamine | |
| Other names
DCPDAT | |
| Identifiers | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| Properties | |
| C9H7Cl2N5 | |
| Molar mass | 256.09 g·mol−1 |
| Pharmacology | |
| None | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
References
- Satoh, H; Amagase, K; Takeuchi, K (2013). "Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats". The Journal of Pharmacology and Experimental Therapeutics. 348 (2): 227–35. doi:10.1124/jpet.113.208991. PMID 24254524. S2CID 23740642.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.